Hypothesizing that UCP2 may influence insulin secretion by modifying the ATP/ADP ratio within pancreatic islets, we have investigated the expression of intraislet UCP2 gene in rats showing insulin oversecretion (non-diabetic Zucker fa/fa obese rats, glucose-infused Wistar rats) or insulin undersecretion (fasting and mildly diabetic rats). We found that in Zucker fa/fa obese rats, hyperinsulinemia (1222 4-98 pmol/1 vs. 128 4-22 pmol/1 in lean Zucker rats) was accompanied by a significant increase in UCP2 mRNA levels. In rat submitted to a 5 day infusion with glucose, hyperinsulinemia (1126 4-101 pmol/l vs. 215 4-25 pmol/1 in Wistar control rats), coincided with an enhanced intraislet UCP2 gene expression, whereas a 8h or a 2 day-infusion did not induce significant changes in UCP2 mRNA expression. In rats made hypoinsulinemic and mildly diabetic by the injection of a low dose of streptozotocin, and in 4-day-fasting rats (plasma insulin 28 4-5 pmol/1) UCP2 gene expression was sharply decreased. A 3-day-fast was ineffective. The data show the existence of a time-dependent correlation between islet mRNA UCP2 and insulin that may be interpreted as an adaptative response to prolonged insulin excess.
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INTRODUCTION
The uncoupling protein-1 (UCP1) mediates the proton leak in the mitochondria of the brown adipose tissue (BAT) and promotes uncoupling fuel oxidation from ADP phosphorylation, t1 '21 This process is involved in thermoregulation and the control of energy balance. TM Until recently, the contribution of this pathway to the regulation of energy expenditure and ATP synthesis was considered as restricted to neonate mammalians and rodents because BAT is present only in small amounts in non-rodent adult mammalians including humans. 21 The discovery of homologs of UCP i.e.,
UCP2
[4"51 and UCP3, [6- [4, 11] because it has been detected in the pancreas contrarily to the other isoforms. This study was further stimulated by the fact that the UCP2 gene is localized to a region of rat chromosome 1 linked to glucose homeostasis in the Wistar rat. I121 This region also includes the gene for the sulphonylurea receptor, 131 involved in insulin secretion. [14] MATERIALS AND METHODS
Animals
Three-month-old male Wistar rats were used. (Fig. 1) . Plasma insulin was 10-fold higher in obese Zucker rats compared to lean Zucker rats (Fig. 1) .
Glucose-infused Rats
Sustained and steady hyperglycemia of about 20mmol/1 was produced in rats infused with glucose during 8h, or 2 days or 5 days. As a result, insulinemia was dramatically increased (Fig. 1) . In both hyperglycemic-hyperinsulinemic groups, the glucose and insulin plateaus were reached after 4h of infusion with glucose (data not shown).
STZ Rats
Two days after STZ injection, plasma glucose and insulin concentrations were, as compared to controls, significantly increased and decreased, respectively (Fig. 3) .
Fifteen days after STZ injection, STZ rats were hyperglycemic and hypoinsulinemic compared to control Wistar rats (Figs. 2 and 3) . Moreover, glucose tolerance and glucose-induced insulin secretion were impaired as reflected in the AG and the AI/AG, respectively (Fig. 2) histochemistry (Fig. 4) (Fig. 1) . Neither a 8h nor a 2-day infusion with glucose did not result in any significant change in UCP2 gene expression, whereas rats infused with glucose during 5 days showed higher UCP2 mRNA levels than controls (Fig. 1) . In STZ rats studied 15 days after the injection of the drug, UCP2 mRNA levels were clearly decreased compared to Wistar non diabetic rats (Fig. 2) . When the rats were studied 2 days after the injection no change in islet UCP2 gene expression could be observed. Islet UCP2 gene expression was also markedly lowered after a 4-day fast but a 3-day fast failed to alter this parameter (Fig. 2) . UCP2 mRNA levels were clearly increased in non-diabetic fa/fa obese Zucker rats which are highly hyperinsulinemic and normoglycemic. Hyperinsulinemia associated with insulin resistance has been long recognized as one of the main characteristics of these rats.
[151 Oversecretion of insulin in response to many secretagogues is present very early, before weaning i.e., when obesity is not yet detectable. 21] To confirm and precise the relationship between UCP2 mRNA and insulin release in vivo, we infused Wistar rats with glucose to provoke hyperinsulinemia and the infusion rate was adjusted to reach plasma insulin levels similar to those of obese fa/fa Zucker rats. When glucose infusion and consequently hyperinsulinemia lasted 5 days, an increase in UCP2 mRNA was observed. On the contrary, the increase in plasma insulin concentration resulting from a 8h or even a 2 day infusion with glucose, was not accompanied by significant changes in islet UCP2 mRNA. The fact that insulin oversecretion precedes the increase in islet UCP2 mRNA suggests that the increase in UCP2 gene expression could be a consequence of insulin oversecretion but cannot be an inducer of increased pancreatic islet function. Moreover, combined with the fact that hyperinsulinemia was established for a very long time in 3 month-old fa/fa obese Zucker rats used in our study, this suggests that, apart plasma insulin level, the duration of insulin oversecretion is of cucial importance in islet UCP2 gene expression.
If the level of UCP2 mRNA in pancreatic islets is correlated with islet function it could logically be expected that pancreatic islet underfunction is accompanied by UCP2 mRNA underexpression. To assess this point we used two models. 
